Literature DB >> 8176464

Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.

Y Choi1, R A Hawkins, S C Huang, R C Brunken, C K Hoh, C Messa, E U Nitzsche, M E Phelps, H R Schelbert.   

Abstract

UNLABELLED: The liver plays an important role in glucose homeostasis. PET studies with 2-[F-18]fluoro-2-deoxy-D-glucose (FDG) of the liver (e.g., in neoplasms) require an understanding of the effects of dietary conditions on hepatic FDG uptake.
METHODS: Twenty studies were performed on 10 normal volunteers (ages 24 +/- 4) after fasting 4 to 19 hr and again after oral consumption of 100 g of dextrose to investigate tracer kinetic model configurations of FDG in the normal liver and to evaluate the impact of oral glucose on liver in normal subjects. Dynamic PET images were acquired for about 1 hr using a Siemens/CTI 931 tomograph.
RESULTS: A three-compartment model with an input function delay time parameter was the statistically preferred model configuration. The model estimated transport rate constant from plasma to liver, K1, increased significantly (p < 0.05) from 0.864 +/- 0.136 ml/min/g in fasting studies to 1.058 +/- 0.269 ml/min/g in postglucose studies. Glucose loading also significantly increased (p < 0.01) the rate constant for FDG phosphorylation, k3, from 0.005 +/- 0.003 min-1 in fasting studies to 0.013 +/- 0.007 min-1 in postglucose administration and, consequently, significantly increased both the phosphorylation fraction (k3/(k2 + k3)) and the influx constant (K1k3/(k2 + k3)). No significant differences in the liver-to-plasma transport rate constant, k2, dephosphorylation constant, k4, or distribution volume of FDG (K1/(k2 + k3)) were observed.
CONCLUSION: Dynamic FDG-PET studies can be used to evaluate kinetics of liver glucose metabolism. The results indicate that dietary conditions have a significant effect on hepatic FDG kinetics. Because of the higher net FDG uptake by normal liver after glucose loading, fasting conditions are preferred for FDG liver tumor studies to increase the tumor-to-background contrast.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176464

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  30 in total

1.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.

Authors:  P Iozzo; R Lautamaki; F Geisler; K A Virtanen; V Oikonen; M Haaparanta; H Yki-Jarvinen; E Ferrannini; J Knuuti; P Nuutila
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

2.  Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study.

Authors:  Mingzan Zhuang; Nicolas A Karakatsanis; Rudi A J O Dierckx; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

3.  Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function.

Authors:  Guobao Wang; Michael T Corwin; Kristin A Olson; Ramsey D Badawi; Souvik Sarkar
Journal:  Phys Med Biol       Date:  2018-07-24       Impact factor: 3.609

4.  Patlak image estimation from dual time-point list-mode PET data.

Authors:  Wentao Zhu; Quanzheng Li; Bing Bai; Peter S Conti; Richard M Leahy
Journal:  IEEE Trans Med Imaging       Date:  2014-04       Impact factor: 10.048

5.  Kinetic metrics of 18F-FDG in normal human organs identified by systematic dynamic total-body positron emission tomography.

Authors:  Guobing Liu; Hongrong Xu; Pengcheng Hu; Hui Tan; Yiqiu Zhang; Haojun Yu; Xuening Li; Hongcheng Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-08       Impact factor: 9.236

6.  Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Authors:  Osamu Manabe; Markus Kroenke; Tadao Aikawa; Atsuto Murayama; Masanao Naya; Atsuro Masuda; Noriko Oyama-Manabe; Kenji Hirata; Shiro Watanabe; Tohru Shiga; Chietsugu Katoh; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-12-14       Impact factor: 5.952

7.  Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Authors:  Georgia Keramida; Sabina Dizdarevic; Janice Bush; A Michael Peters
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

8.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

9.  Absolute quantitation of myocardial blood flow with (201)Tl and dynamic SPECT in canine: optimisation and validation of kinetic modelling.

Authors:  Hidehiro Iida; Stefan Eberl; Kyeong-Min Kim; Yoshikazu Tamura; Yukihiko Ono; Mayumi Nakazawa; Antti Sohlberg; Tsutomu Zeniya; Takuya Hayashi; Hiroshi Watabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-15       Impact factor: 9.236

10.  Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.

Authors:  Amy S Yu; Hong-Dun Lin; Sung-Cheng Huang; Michael E Phelps; Hsiao-Ming Wu
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.